Q3 2017 Holdings
Filed 2017-11-14 | 63 holdings | $14.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals Inc(ALXN)Call | COM | 015351109 | $4.9K | 35,000 | 0.0% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $5.4K | 83,700 | 0.0% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $5.6K | 65,000 | 0.0% |
| Bristol Myers Squibb Co(BMY) | COM | 110122108 | $5.7K | 90,000 | 0.0% |
| Proshares TR(BIB) | PSHS ULT NASB | 74347R214 | $8.0K | 130,500 | 0.1% |
| Akebia Therapeutics Inc(AKBA) | COM | 00972D105 | $413.0K | 21,009 | 2.9% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $535.0K | 4,955 | 3.8% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $589.0K | 15,639 | 4.2% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $741.0K | 133,500 | 5.2% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $1.9M | 19,926 | 13.1% |
| Biogen Inc(BIIB) | COM | 09062X103 | $2.1M | 6,687 | 14.8% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $2.2M | 33,347 | 15.8% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $5.6M | 47,459 | 39.5% |